Species distribution and in vitro antifungal susceptibility patterns of 75 clinical isolates of Fusarium spp. from northern Italy

被引：63

作者：

Tortorano, Anna Maria ^{[1
]}

Prigitano, Anna ^{[1
]}

Dho, Giovanna ^{[1
]}

Esposto, Maria Carmela ^{[1
]}

Gianni, Claudia ^{[2
]}

Grancini, Anna ^{[3
]}

Ossi, Cristina ^{[4
]}

Viviani, Maria Anna ^{[1
]}

机构：

[1] Univ Milan, Dept Publ Hlth Microbiol Virol, I-20133 Milan, Italy

[2] Hosp San Raffaele, Dept Dermatol, Inst Sci, I-20132 Milan, Italy

[3] Fdn IRCCS Osped Maggiore Policlin, Microbiol Lab, Milan, Italy

[4] Ist Sci San Raffaele, Laboraf, I-20132 Milan, Italy

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2008年 / 52卷 / 07期

关键词：

D O I：

10.1128/AAC.00272-08

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Fusarium isolates from 75 Italian patients were identified by molecular methods, and their susceptibilities to antifungals were tested in vitro. Fusarium verticillioides was the species most frequently isolated from deep-seated infections, and F. solani was the species most frequently isolated from superficial infections. F. solani isolates showed high azole MICs, while F. verticillioides isolates showed low posaconazole MICs.

引用

收藏

页码：2683 / 2685

页数：3

相关论文

共 14 条

[1] Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species [J].

Arikan, S ;

Lozano-Chiu, M ;

Paetznick, V ;

Nangia, S ;

Rex, JH .

JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (12) :3946-3951

[2] Universal in vitro antifungal resistance of genetic clades of the Fusarium solani species complex [J].

Azor, Monica ;

Gene, Josepa ;

Cano, Josep ;

Guarro, Josep .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (04) :1500-1503

[3] Use of the DiversiLab System for species and strain differentiation of Fusarium species isolates [J].

Healy, M ;

Reece, K ;

Walton, D ;

Huong, J ;

Frye, S ;

Raad, II ;

Kontoyiannis, DP .

JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (10) :5278-5280

[4] A species-specific PCR assay based on the calmodulin partial gene for identification of Fusarium verticillioides, F-proliferatum and F-subglutinans [J].

Mulè, G ;

Susca, A ;

Stea, G ;

Moretti, A .

EUROPEAN JOURNAL OF PLANT PATHOLOGY, 2004, 110 (5-6) :495-502

[5] Cutaneous infection by Fusarium species in healthy and Immunocompromised hosts:: Implications for diagnosis and management [J].

Nucci, M ;

Anaissie, E .

CLINICAL INFECTIOUS DISEASES, 2002, 35 (08) :909-920

[6] Fusarium Infections in Immunocompromised Patients [J].

Nucci, Marcio ;

Anaissie, Elias .

CLINICAL MICROBIOLOGY REVIEWS, 2007, 20 (04) :695-704

[7] Multiple evolutionary origins of the fungus causing Panama disease of banana: Concordant evidence from nuclear and mitochondrial gene genealogies [J].

O'Donnell, K ;

Kistler, HC ;

Cigelnik, E ;

Ploetz, RC .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (05) :2044-2049

[8] In vitro activities of investigational triazoles against Fusarium species:: Effects of inoculum size and incubation time on broth microdilution susceptibility test results [J].

Paphitou, NI ;

Ostrosky-Zeichner, L ;

Paetznick, VL ;

Rodriguez, JR ;

Chen, EN ;

Rex, JH .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (10) :3298-3300

[9] Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex [J].

Perfect, JR .

CLINICAL INFECTIOUS DISEASES, 2005, 40 :S401-S408

[10] Voriconazole treatment for less-common, emerging, or refractory fungal infections [J].

Perfect, JR ;

Marr, KA ;

Walsh, TJ ;

Greenberg, RN ;

DuPont, B ;

de la Torre-Cisneros, J ;

Just-Nübling, G ;

Schlamm, HT ;

Lutsar, I ;

Espinel-Ingroff, A ;

Johnson, E .

CLINICAL INFECTIOUS DISEASES, 2003, 36 (09) :1122-1131